Cancer Stem Cell Properties: Inhibition of SIRT1 has been shown to reduce cancer stem cell populations and block EMT in breast cancer cells, indicating that SIRT1 contributes to the maintenance of stem-like properties and metastatic potential in TNBC [94]. Here, SIRT1 is linked to cancer.